<?xml version="1.0" encoding="UTF-8"?>
<p id="Par15">Currently, the Global Initiative on Sharing All Influenza Data (GISAID) (
 <ext-link ext-link-type="uri" xlink:href="http://www.gisaid.org" xmlns:xlink="http://www.w3.org/1999/xlink">http://www.gisaid.org</ext-link>), have analyzed over 75,853 full genomes of SARS-CoV-2 up to August 30, 2020, with the predominance of the GR clade (23,502), followed by the G clade (17,176), and the GH clade (16,416), among others (Fig.Â 
 <xref rid="Fig1" ref-type="fig">1</xref>).
</p>
